Seong-Ho Kang
2PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Apr 09, 2020
CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.Hyung-Seung Jin, Minkyung Ko, Da-Som Choi
|Dec 15, 2018
Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma.Seong-Ho Kang, Bhumsuk Keam, Yong-Oon Ahn
Pageof 1
